Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development for intranasal delivery. By modulating ...

Tiziana Life Sciences has announced promising results from an open-label study of its investigational multiple sclerosis (MS) ...

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients.All patients experienced stabilization of Expanded Disability ...

Broad rim lesions, which have wider rims of immune cells, are associated with faster disease progression in MS, per a study.

Multiple sclerosis (MS) can be unpredictable, with flares of debilitating symptoms like weakness, numbness, thought processing issues, and balance challenges. Managing your diet along with other ...

When you have chronic disease, you’re not like most people. Multiple sclerosis (MS), autoimmune forms of arthritis, and many other conditions can cause extreme fatigue. On a bad day, you may not ...

"A suitable radiotracer that can noninvasively map synucleinopathies through PET imaging will lead to breakthroughs ... results in distinguishing multiple system atrophy from other ...

The research combined PET imaging data from 114 Finnish MS patients with post ... Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis, ...

As a former claims handler and fraud investigator, Jason Metz has worked on a multitude of complex and multifaceted claims. The insurance industry can be seemingly opaque, and Jason enjoys ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple sclerosis (MS). The research combined PET imaging data from 114 ...